[
  {
    "ts": null,
    "headline": "Raymond James Reiterates AbbVie (ABBV) Outperform Recommendation",
    "summary": "Raymond James Reiterates AbbVie (ABBV) Outperform Recommendation",
    "url": "https://finnhub.io/api/news?id=eda514e8f3e7cf235e6448b41eb130209b7104a4f73e36106d2505c7eece24da",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760736042,
      "headline": "Raymond James Reiterates AbbVie (ABBV) Outperform Recommendation",
      "id": 137129646,
      "image": "",
      "related": "ABBV",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=eda514e8f3e7cf235e6448b41eb130209b7104a4f73e36106d2505c7eece24da"
    }
  },
  {
    "ts": null,
    "headline": "NEW YORK MARKET CLOSE: Shares higher as banking, China fears abate",
    "summary": "NEW YORK MARKET CLOSE: Shares higher as banking, China fears abate",
    "url": "https://finnhub.io/api/news?id=0b508ca61591089cc3e91f6deddcbcb1b23532e9a76437fa64d653964ad148db",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760733123,
      "headline": "NEW YORK MARKET CLOSE: Shares higher as banking, China fears abate",
      "id": 137129248,
      "image": "",
      "related": "ABBV",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0b508ca61591089cc3e91f6deddcbcb1b23532e9a76437fa64d653964ad148db"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie: \"Strong Buy\" On Rinvoq Expansions And Immunology Pipeline Addition",
    "summary": "I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.",
    "url": "https://finnhub.io/api/news?id=cc4b4801a3fb8d6c709f79fc0a5d8eb396d05f1c040cb36d6dc6d009798f3848",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760718872,
      "headline": "AbbVie: \"Strong Buy\" On Rinvoq Expansions And Immunology Pipeline Addition",
      "id": 137129251,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212517857/image_2212517857.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.",
      "url": "https://finnhub.io/api/news?id=cc4b4801a3fb8d6c709f79fc0a5d8eb396d05f1c040cb36d6dc6d009798f3848"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=3270c51faa1014c77841635d915be7f1149ddef0d6d6cd32d918b4d96bb5fab8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760718660,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 137136819,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=3270c51faa1014c77841635d915be7f1149ddef0d6d6cd32d918b4d96bb5fab8"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin",
    "summary": "AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin.",
    "url": "https://finnhub.io/api/news?id=b3b76bcb6004781fd5a59b74e4dd268a5f19315095709c13bbd8e3f3f1759a65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760706000,
      "headline": "AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin",
      "id": 137125707,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin.",
      "url": "https://finnhub.io/api/news?id=b3b76bcb6004781fd5a59b74e4dd268a5f19315095709c13bbd8e3f3f1759a65"
    }
  }
]